23andMe, Inc., a leading consumer genetics and research company, and VG Acquisition Corp. (NYSE: VGAC), a special purpose acquisition company sponsored by Virgin Group, announced Wednesday the completion of their previously announced business combination. The transaction uniquely positions 23andMe to revolutionize personalized healthcare and therapeutic development through human genetics. The combined company is called 23andMe Holding Co. and will be traded on The Nasdaq Global Select Market (“Nasdaq”) beginning on June 17, 2021 under the new ticker symbol “ME” for its Class A Common shares and “MEUSW” for its public warrants.
Read the full article: 23andMe Successfully Closes Its Business Combination with VG Acquisition Corp. //
Source: https://www.globenewswire.com/news-release/2021/06/16/2248567/0/en/23andMe-Successfully-Closes-its-Business-Combination-with-VG-Acquisition-Corp.html